The Flow Cytometry Market is expected to register a CAGR of 8.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Product {Instruments (Cell Analyzers and Cell Sorters), Reagents & Consumables, Software, Accessories, Services}, By Technology (Cell-based, and Bead-based), By Application (Research, Industrial, and Clinical), By End-use (Commercial Organizations, Hospitals, Academic Institutes, and Clinical Testing Labs). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
The report Flow Cytometry Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Flow Cytometry Market: Strategic Insights
The regional trends and factors influencing the Flow Cytometry Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Flow Cytometry Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ XX million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2025 - 2031) | 8.6% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Flow Cytometry Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Flow Cytometry Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The research report on the Flow Cytometry Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
The List of Companies
1. Thermo Fisher Scientific, Inc.
2. Merck KGaA
3. Novozymes
4. Agilent Technologies
5. Amyris
6. Genscript
7. Integrated DNA Technologies, Inc.
8. Twist Bioscience
9. New England Biolabs (NEB)
10. Synthetic Genomics, Inc.
11. Sony Biotechnology, Inc.
12. Stratedigm, Inc.
The flow cytometry market is estimated to grow with a CAGR of 8.6% from 2023 to 2031.
Asia Pacific region is likely to witness fastest growth rate during the forecast period.
The market drivers include growing prevalence of cancer and immunodeficiency and increasing use of flow cytometry in clinical research are driving the flow cytometry market
The flow cytometry market majorly consists of the players such as Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc. among others.
Technological advancements are likely to remain the key trend during the forecast period
North America dominated the flow cytometry market in 2023